Shionogi B.V.
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
33 Kingsway, London, Greater London, WC2...Phone Number
+44 2030534200Website
www.shionogi.euRevenue
$316.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Shionogi B.V.
Founded in 1878, Shionogi B.V. is the European headquarters of Shionogi & Company. The company is a research-led organization, defined by a distinct openness and close partnership approach to creating vaccines and medicines spanning pain, infectious diseases, metabolic disorders, womens health, and oncology. The company is headquartered in London, United Kingdom.Explore more
Popular SearchesShionogi BVShionogi & Co LtdShionogi LtdShionogi EuropeanShionogi toSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shionogi B.V. your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Shionogi B.V. recently announced quarterly report
Check out if Shionogi B.V. is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Shionogi B.V.
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Shionogi B.V. has new funding data
Check if Shionogi B.V. has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Shionogi B.V. launches new products
Shionogi B.V., which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Shionogi B.V. had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Shionogi B.V.
Compare insights from companies similar to Shionogi B.V., focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Shionogi B.V.
$316.5M
51-200
Private
-
1878
N/A
$216.8M
51-200
Public
$1.1B
1991
SK
Stephen KetchumExecutive VP & President, Research & Development & Chief Scientific Officer
Company Profile Activity
Activity Insights
Shionogi B.V. is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Shionogi B.V. is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Shionogi B.V..
Shionogi B.V. Tech Stack
A closer look at the technologies used by Shionogi B.V.
Shionogi B.V. News & Media
ECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment
OSAKA, Japan--(BUSINESS WIRE)--Shionogi presents ensitrelvir COVID-19 data at ECCMID 2023Shionogi’s Antibiotic, FETCROJA® (cefiderocol), Is Now Available in the Netherlands
OSAKA, Japan & AMSTERDAM--(BUSINESS WIRE)--Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter "Shionogi"), today announces that its antibiotic, cefiderocol, is now available in the Netherlands for the treatment of infections due to aerobic Gram-negative bacteria in adults (18 years or older) with limited treatment options.1 Cefiderocol is available to purchase in the Netherlands through Alloga (Nederland) B.V. The Netherlands, home to Shionogi’s European HeadquartersShionogi’s Innovative Antibiotic, FETCROJA® (cefiderocol), Is Now Available in Denmark
OSAKA, Japan & AMSTERDAM--(BUSINESS WIRE)--Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter "Shionogi"), today announces that its innovative antibiotic, cefiderocol, is now available in Denmark for the treatment of infections due to aerobic Gram-negative bacteria in adults (18 years or older) with limited treatment options.1 Pharmacies in Denmark are expected to place orders for cefiderocol via the online ordering portal, Serviceløsningerne (further details below).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Shionogi B.V.
Sign Up For FreeTo access detailed company insights
Founded in 1878, Shionogi B.V. is the European headquarters of Shionogi & Company. The company is a research-led organization, defined by a distinct openness and close partnership approach to creating vaccines and medicines spanning pain, infectious diseases, metabolic disorders, womens health, and oncology. The company is headquartered in London,... Read More
